Table 2.
Semiquantitative evaluation—histology sections of liver, spleen, kidney, and abdominal wall for immune cell presence and fibrosis.
| Organ | Parameter | CHX | Control | ||
|---|---|---|---|---|---|
| 1 Week | 3 Weeks | 1 Week | 3 Weeks | ||
| liver | lymphocytes | ++ | +/++ | - | - |
| neutrophils | ++ | +/++ | - | - | |
| fibrosis | + | ++ | - | - | |
| spleen | lymphocytes | -/+ | -/+ | - | -/+ |
| neutrophils | + | ++ | -/+ | -/+ | |
| capsule | + | + | -/+ | + | |
| kidney | PMN/MNC | -/+ | -/+ | - | - |
| fibrosis | -/+ | -/+ | - | - | |
| Abd. wall peritoneum |
PMNs | +/++ | +/++ | - | - |
| MNCs | + | -/+ | - | - | |
| edema | +/++ | +++ | - | - | |
| fibroblasts | + | ++ | - | - | |
| Abd. wall injury |
depth | up to 25% | up to 25% | - | - |
No change (-), scarce (-/+), mild (+), moderate (++), severe (+++). CHX: chlorhexidine gluconate, PMNs: polymorphonuclear cells, MNCs: mononuclear cells.